Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital

Annals of Saudi Medicine

Volumn 31, Issue 4, 2011, Pages 371-375

  Al Omran, Mohammed ^a   Verma, Subodh ^b   Lindsay, Thomas ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; ORAL ANTIDIABETIC AGENT; RAMIPRIL;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SMOKING; TEACHING HOSPITAL;

EID: 79961136826     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.83219     Document Type: Article

References (31)

1. The TASC Working Group. Management of Peripheral Arterial Disease (PAD);Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 2001; 31:S1-288.
2. Hertzer NR. Clinical experience with pre-operative coronary angiography. J Vasc Surg 1985;2:510-4.
3. Alexandrova NA, Gibson WC, Norris JW, Mag-gisano R. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 1996;23:645-9. (Pubitemid 26131823)
4. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
5. Fowkes FG, Housley E, Riemersma RA, Ma-cintyre CC, Cawood EH, Prescott RJ, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331-40.
6. Lu JT, Creager MA. The relationship of cigarette smoking to peripheral arterial disease. Rev Cardio-vasc Med 2004;5:189-93. (Pubitemid 40011950)
7. Willigendael EM, Teijink JA, Bartelink ML, Kuiken BW, Boiten J, Moll FL, et al. Influence of smoking on incidence and prevalence of periph eral arterial disease. J Vasc Surg 2004;40:1158-65. (Pubitemid 40037284)
8. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-12. (Pubitemid 30609442)
9. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
10. Heart Protection Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7-22.
11. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo-cardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
12. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-654.
13. Abramson BL, Huckell V, Anand S, Forbes T, Gupta A, Harris K, et al. Canadian Cardiovascular Society Consensus Conference: Peripheral arterial disease-executive summary. Can J Cardiol 2005;21:997-1006. (Pubitemid 41723264)
14. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72. (Pubitemid 43947981)
15. Kinikini D, Sarfati MR, Mueller MT, Kraiss LW. Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: An opportunity we cannot afford to miss. J Vasc Surg 2006;43:781-7.
16. Hackam DG, Tan MK, Lin PJ, Mehta PG, Jaffer S, Kates M, et al. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries. J Vasc Surg 2006;44:776-81. (Pubitemid 44444934)
17. Anand SS, Kundi A, Eikelboom J, Yusuf S. Low rates of preventive practices in patients with peripheral vascular disease. Can J Cardiol 1999;15:1259-63. (Pubitemid 30006765)
18. Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ 2004;171:1189-92. (Pubitemid 39518012)
19. Gen TL, Sieunarine K, Eikelboom J, Prender-gast FJ, Goodman MA, Joesbury K, et al. Subop-timal preventive practices in patients with carotid and peripheral vascular occlusive disease in a tertiary referral setting. ANZ J Surg 2003;73:932-7. (Pubitemid 37500589)
20. Rehring TF, Sandhoff BG, Stolcpart RS, Me-renich JA, Hollis HW Jr. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg 2005;41:816-22. (Pubitemid 40693804)
21. Sukhija R, Yalamanchili K, Aronow WS, Kakar P, Babu S. Clinical characteristics, risk factors, and medical treatment of 561 patients with peripheral arterial disease followed in an academic vascular surgery clinic. Cardiol Rev 2005;13:108-10. (Pubitemid 40279880)
22. Bradley L, Kirker SG. Secondary prevention of arteriosclerosis in lower limb vascular amputees: A missed opportunity. Eur J Vasc Endovasc Surg 2006;32:491-3. (Pubitemid 44490341)
23. Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: Insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 2002;106:1909-12. (Pubitemid 35176293)
24. World Health Organization. The world health report 2004. Available from: http://www.who.int/features/qa/18/en. [Last Accessed on 2006 Aug 25].
25. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-39.
26. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739-45. (Pubitemid 27106227)
27. Hirsch AT, Gloviczki P, Drooz A, Lovell M, Creager MA. Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. J Vasc Surg 2004;39:474-81. (Pubitemid 38174339)
28. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24. (Pubitemid 33015522)
29. Al Omran M, Lindsay TF, Major J, Jawas A, Leiter LA, Verma S. Perceptions of Canadian Vascular Surgeons toward Pharmacological Risk Reduction in Patients with Peripheral Arterial Disease. Ann Vasc Surg 2006;20:555-63. (Pubitemid 44953067)
30. McDermott MM, Hahn EA, Greenland P, Cella D, Ockene JK, Brogan D, et al. Atherosclerotic risk factor reduction in peripheral arterial disease: Results of a national physician survey. J Gen Intern Med 2002;17:895-904. (Pubitemid 35471987)
31. Cassar K, Belch JJ, Brittenden J. Are national cardiac guidelines being applied by vascular surgeons? Eur J Vasc Endovasc Surg 2003;26:623-8. (Pubitemid 37461778)